2013
2013

Launch in Europe

Launch in Europe

UNISTRAIN® PRRS was presented at Edinburgh in 2013 within the framework of the ESPHM. The arrival of UNISTRAIN® PRRS provided an efficient alternative to European producers to better control PRRS with a live vaccine with potent immunogenic features and safety proved fulfilling all the EMA requirements.

2014
2014

Arrival in Asia

Arrival in Asia

In January 2014, UNISTRAIN® PRRS was launched in South Korea and it was received with great expectation. In South Korea, UNISTRAIN® PRRS demonstrated the capacity of the vaccine to proper control PRRSV2 and PRRSV1.

2014

Combination with ERYSENG® PARVO

Combination with ERYSENG® PARVO

The first and unique combination of a PRRS live vaccine and a bivalent Erysipelas and porcine parvovirus vaccine was registered in Europe in 2014. This combination provides to the market a convenient and welfare-friendly vaccination to cover 3 of the most important reproductive diseases for the breeding herd.

2015
2015

Birth of prrscontrol.com

Birth of prrscontrol.com

PRRS is the trickiest disease with the highest economic impact in the swine industry. Prrscontrol.com was born to provide high quality and updated technical information to approach PRRS. Knowledge, video tutorials, experts answering questions and tools to control PRRS are the key contents you can find in.

2016
2016

Launch of Hipradermic®

Launch of Hipradermic®

With the official registration of the intradermal route for UNISTRAIN® PRRS, HIPRA presented the ID needle-free device for UNISTRAIN® PRRS: Hipradermic®. With this innovative device, HIPRA started the way of animal welfare, vaccination traceability, quality vaccination and better immunity that represents a step forward on PRRS control. Hipradermic® is an end to end project completely made by HIPRA.

2018
2018

In-house sequencing service at Diagnos

In-house sequencing service at Diagnos

In 2018, due to the growing demand for a deeper understanding of PRRSV epidemiology, HIPRA ceased outsourcing sequencing services and established an in-house, high-quality ORF5 sequencing service for our customers. This initiative entailed a significant investment in equipment, facilities, personnel and training.

2019
2019

Combination with AUSKIPRA® GN

Combination with AUSKIPRA® GN

The first and unique combination of two live vaccines, PRRS and Aujeszky vaccine, was registered. Moreover, this was the first combination that can be administered by both ID and IM route. This innovative combination provides to the market a convenient and welfare-friendly vaccination to cover two major swine diseases.

2021
2021

ORF2-7 sequencing at Diagnos

ORF2-7 sequencing at Diagnos

The complexity of the virus requires a better understanding of it. That’s why an upgrade to the sequencing services was introduced in 2021: partial sequencing from ORF2 to ORF7 allows our customers to gain a deeper understanding of the virus’s origin, evolution, and complexity.

2023
2023

Arrival in Japan

Arrival in Japan

At the beginning of 2023, HIPRA got the marketing authorization of UNISTRAIN® PRRS in Japan. This confirms UNISTRAIN® PRRS as a useful tool for controlling PRRS in Asia and demonstrates the cross-protection capacity of UNISTRAIN® PRRS against any type of PRRS viruses.

 



    close-link

      NEWSLETTER
      DON'T MISS ANY UPDATES

      [mc4wp_checkbox]
      I have read and agree to the Privacy Policy and Basic information on Data Protection.
      close-image

      Informazioni di base sulla protezione dei dati personali:

      Titolare del trattamento: LABORATORIOS HIPRA, S.A.
      Finalità: Gestione del rapporto contrattuale e/o commerciale con HIPRA, incluso l’invio di notizie, promozioni e inviti a eventi sponsorizzati da HIPRA.
      Base giuridica: Esecuzione del rapporto contrattuale e del legittimo interesse di HIPRA.
      Destinatari: Terzi a cui HIPRA ha affidato servizi di cloud computing, sicurezza, auditing, mailing, supporto tecnico e informatico, nonché società del suo gruppo.
      Diritti: Richiedere l'accesso e la rettifica o la cancellazione dei dati personali e altri diritti come spiegato nelle informazioni aggiuntive. Puoi vedere le informazioni aggiuntive dettagliate sulla protezione dei dati nella nostra Informativa sulla privacy.

      Per ulteriori informazioni, puoi consultare le nostre informazioni dettagliate sulla Protezione dei dati.

      Basic Personal Data Protection information:

      Controller: LABORATORIOS HIPRA, S.A.
      Purposes: Managing the contractual and/or business relationship with HIPRA, including sending news, promotions and invitations to events sponsored by HIPRA.
      Lawful basis: Performance of the contractual relationship and HIPRA's legitimate Interest.
      Recipients: Third parties to which HIPRA has entrusted cloud computing, security, auditing, mailing, technical and computer support services, as well as companies in its group.
      Rights: Request access to and rectification or erasure of personal data and other rights as explained in the additional information. You can seeview the detailed additional information about data protection in our Privacy Policy.

      For further information, please check our detailed information on Data Protection.

      Información básica sobre protección de datos:

      Responsable del tratamiento: LABORATORIOS HIPRA, S.A.
      Propósitos: Gestionar la relación contractual y comercial con HIPRA, incluido el envío de noticias, promociones e invitaciones a eventos patrocinados por HIPRA.
      Fundamentos legales: Cumplimiento de la relación contractual e interés legítimo de HIPRA.
      Destinatarios: Terceros a los que HIPRA ha encargado las tareas de computación en la nube, seguridad, auditoría, correo, servicios de soporte técnico e informático, así como empresas de su grupo.
      Derechos: Solicitar el acceso y la rectificación o eliminación de los datos personales y otros derechos, tal como se explica en la información adicional. Puede ver la información adicional detallada sobre la protección de datos en nuestra Política de Privacidad.

      Para obtener más información, consulte nuestra información detallada sobre Protección de datos.